Please assess the completion status of the following clinical trial:

Trial Title: Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with asthma as determined by ICD-9 codes and asthma drug use~* at least 12 years of age~* discharged from an initial Emergency Department visit within 12 months~Exclusion Criteria:~* Subjects with COPD or treatment for COPD

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluticasone propionate/salmeterol combination ED MD (Type: None): Asthma subjects discharged from an institution after treatment for severe asthma exacerbation that receive fluticasone propionate/salmeterol combination from the ED physician
- Fluticasone propionate/salmeterol combination OP MD (Type: None): Asthma subjects discharged from an institution after treatment for severe asthma exacerbation that receive fluticasone propionate/salmeterol combination from the OP physician

Based on this trial design, predict the completion outcome and termination type (if applicable).